Gladstone Institutional Advisory’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,967
Closed -$387K 438
2020
Q4
$387K Buy
7,967
+460
+6% +$22.7K 0.08% 197
2020
Q3
$377K Buy
7,507
+667
+10% +$34.3K 0.09% 168
2020
Q2
$349K Buy
+6,840
New +$332K 0.09% 164

Other funds holding SNY

Gladstone Institutional Advisory's SNY Position: Q1 2021 in Review

Gladstone Institutional Advisory sold out of Sanofi (SNY) in Q1 2021, closing a stake of 7,967 shares — an estimated $387K sold.

Gladstone Institutional Advisory first reported a position in SNY in Q2 2020 and held it in 3 quarters. The position peaked at $387K in Q4 2020. 572 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Gladstone Institutional Advisory reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 7,967 Sanofi shares in Q1 2021, an estimated $387K.
  • Gladstone Institutional Advisory first reported a position in Sanofi in Q2 2020 and held it in 3 quarters.
  • Gladstone Institutional Advisory's Sanofi position peaked at $387K in Q4 2020.
  • 572 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2021, filed 17 May 2021.